More on IONS
Data
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $58.13 |
|
|||
| Open | $58.36 | ||||
| 52 Wk High | $62.68 | ||||
| 52 Wk Low | $19.59 | ||||
| Day High | $58.96 | ||||
| Day Low | $57.78 | ||||
| P/E | N/A | ||||
| EPS | $0.00 | ||||
| Volume | 2,664,986 | ||||
- Ionis Pharmaceuticals (IONS) PT Raised to $61 at BMO Capital
- H.C. Wainwright Reiterates Buy Rating on Ionis Pharmaceuticals (IONS)
- FDA approves Ionis Pharma's therapy to treat rare genetic disorder
- FDA approves first treatment for Alexander disease
- H.C. Wainwright Reiterates Buy Rating on Ionis Pharmaceuticals (IONS)
- JPMorgan Reiterates Overweight Rating on Ionis Pharmaceuticals (IONS)
- Alnylam stock drops on rival heart trial: Why analysts see core business safe
- Canaccord Reiterates Buy Rating on Ionis Pharmaceuticals (IONS)
- Ionis to present olezarsen and ION775 data at ESC Congress 2026
- Ionis to present new data strengthening leadership in the management of severe hypertriglyceridemia (sHTG) at the European Society of Cardiology Congress 2026
Entities mentioned with IONS
- Twitter | View Related Stories »
- FDA | View Related Stories »
- Earnings | View Related Stories »
- ARK | View Related Stories »
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- PDUFA | View Related Stories »
- Definitive Agreement | View Related Stories »
- Show More...
